Oral anticoagulant (OAC) monotherapy vs. dual-antithrombotic therapy (DAT) in patients with atrial fibrillation and coronary artery disease; a meta-analysis of four randomized controlled trials
In patients with AF and stable CAD, OAC monotherapy reduced the risk of major bleeding, with no significant differences in NACE, major ischemic events, or all-cause mortality as compared to DAT.
Authors
- Umair Majeed (ORCID: https://orcid.org/0000-0002-4225-7555)
- Minahil Iqbal (ORCID: https://orcid.org/0000-0002-9320-1228)
- Yatrik M. Shah (ORCID: https://orcid.org/0000-0002-2487-4816)
- Sufyan Shahid (ORCID: https://orcid.org/0009-0002-9236-0822)
- Iftikhar Ali (ORCID: https://orcid.org/0000-0002-5817-8800)
- Hamza Iftikhar
- Naeem Khan Tahirkheli
- Salman Khalid (ORCID: https://orcid.org/0000-0003-4638-9675)
- Mishal Zehra
- Muhammad Abdullah (ORCID: https://orcid.org/0000-0003-1576-4444)
- Muhammad Shuaib Abid
- Ayesha Batool
- Humza Saeed
- Anum Touseef Hussain
- Muzaffar Ali Zahidi
Institutions
- Punjab Institute of Cardiology (PK)
- Rawalpindi Medical University (PK)
- Allama Iqbal Medical College (PK)
- CMH Lahore Medical College and Institute of Dentistry (PK)
- Dow University of Health Sciences (PK)
- Oklahoma Heart Hospital (US)
- Ch. Pervaiz Elahi Institute of Cardiology, Multan
- University of Oklahoma Health Sciences Center (US)
Publication Details
- Journal
- Annals of Medicine and Surgery
- Published
- 2024-12-12
- DOI
- https://doi.org/10.1097/ms9.0000000000002957
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00